“A researcher had a good idea. Good trials were designed and implemented. After an auspicious start, the end results were disappointing. That’s just how it goes.”
Just an observation--somewhat off topic: I met with my primary care --who is also trained in ID yesterday--and she's expressing skepticism about Paxlovid. This is from a good physician in practice. Can you address that at some point? I'm a physician and prescribe it in a health center setting. She's in a private primary care office and is concerned about lack of efficacy and rebound.
Thanks for your efficiency in updating us.
“A researcher had a good idea. Good trials were designed and implemented. After an auspicious start, the end results were disappointing. That’s just how it goes.”
That sums it up it!
Just an observation--somewhat off topic: I met with my primary care --who is also trained in ID yesterday--and she's expressing skepticism about Paxlovid. This is from a good physician in practice. Can you address that at some point? I'm a physician and prescribe it in a health center setting. She's in a private primary care office and is concerned about lack of efficacy and rebound.